Cortland Associates Inc. MO Has $34.03 Million Holdings in Danaher Corporation $DHR

Cortland Associates Inc. MO lifted its holdings in Danaher Corporation (NYSE:DHR) by 0.1% during the second quarter, HoldingsChannel reports. The firm owned 172,273 shares of the conglomerate’s stock after purchasing an additional 105 shares during the period. Danaher comprises 4.0% of Cortland Associates Inc. MO’s investment portfolio, making the stock its 12th biggest position. Cortland Associates Inc. MO’s holdings in Danaher were worth $34,031,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Hills Bank & Trust Co increased its stake in shares of Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after purchasing an additional 53 shares during the period. Worth Financial Advisory Group LLC increased its stake in shares of Danaher by 4.6% in the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock worth $236,000 after purchasing an additional 53 shares during the period. Sageworth Trust Co increased its stake in shares of Danaher by 2.3% in the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after purchasing an additional 54 shares during the period. 1834 Investment Advisors Co. increased its stake in shares of Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 54 shares during the period. Finally, Bruce G. Allen Investments LLC increased its stake in shares of Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after purchasing an additional 54 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Wells Fargo & Company lowered their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 23rd. Bank of America lowered their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Barclays restated an “overweight” rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $246.74.

Danaher Stock Down 1.5%

NYSE DHR opened at $208.63 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock’s 50 day moving average is $200.40 and its two-hundred day moving average is $197.32. The company has a market capitalization of $149.39 billion, a price-to-earnings ratio of 44.39, a PEG ratio of 3.02 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s payout ratio is presently 27.23%.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.